Issn Print: 0923-7534
Publication Date: 2017/10/26
Risks and benefits from CDK inhibitors for advanced HR+ Her 2− breast cancer
C Messina; M Messina; E Zanardi
Author Information: Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.